Group One Trading’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
Group One Trading's LKFT Position: Q3 2026 in Review
Group One Trading reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 99% in Q3 2026, selling an estimated $497K and leaving 221 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #6550.
Group One Trading first reported a position in LKFT in Q3 2018 and has held it in 26 quarters since. The position peaked at $4.82M in Q1 2020. 95 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.
- Group One Trading held 221 shares of Lakefront Biotherapeutics American Depositary Shares worth $6.55K as of Q3 2026.
- Group One Trading sold 17,356 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2026, an estimated $497K.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6550 holding.
- Group One Trading first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2018 and has held it in 26 quarters since.
- Group One Trading's Lakefront Biotherapeutics American Depositary Shares position peaked at $4.82M in Q1 2020.
- 95 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.